CTRI/2017/05/008490已完成未知
Retrospective analysis of efficacy of Gefitinib in Non Small Cell Lung Cancer
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)Age >= 18 years
- •2)Patients diagnosed with stage IV NSCLC
- •3)Patients planned and administered gefitinib as palliative treatment
- •4)ECOG Performance Status 0-3
排除标准
- •1)Age < 18 years
- •2)Patients with lung cancers other than NSCLC
- •3)Patients with active cancer other than NSCLC
研究者
相似试验
已完成
2 期
A Phase II Study of Gefitinib Monotherapy as First-Line Treatment for Elderly Patients with Stage IIIB /IV Adenocarcinoma of the LungJPRN-UMIN000006144Central Japan Lung Study Group32
进行中（未招募）
1 期
Evaluation of efficacy of gefitinib drug in patients with non-small cell tumors with EGFR and TP53 gene mutatioon-small cell lung cancer (NSCLC) at the stageadvanced / metastatic with receptor sensitizing mutation for growth factorepidermal (EGFR)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-002626-20-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA54
已完成
不适用
Clinical study of a combined use of Gefitinib and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000000637Juntendo University, School of Medicine20
已完成
不适用
Phase I/II study of Gefitnib monotherapy as neo-adjuvant chemotherapy for cN2 lung adenocarcinoma with the EGFR mutatioJPRN-UMIN000004807KantoKoshinetsu lung cancer research group20
尚未招募
3 期
A study to compare Gefitinib tablet with Gefitinib and Chemotherapy inEGFR Mutation Positive Lung cancer patientsCTRI/2022/08/044570Tata Memorial Centre